Large-scale testing (Phase 3)Study completedNCT00079937
What this trial is testing
Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma
Who this might be right for
Asthma
Novartis Pharmaceuticals 628